Anika Therapeutics | Umlaufvermögen





Umlaufvermögen Veränderung Datum
Abbott USD 24.84B 371M 2025-09
Agenus USD 133.95M 120.61M 2025-09
Agios Pharmaceuticals USD 1.03B 13.64M 2025-09
Anika Therapeutics USD 101.59M 2.27M 2025-09
Arrowhead Research USD 1.17B 223.75M 2025-12
Enanta Pharmaceuticals USD 204.34M 18.37M 2025-09
Halozyme Therapeutics USD 1.33B 206.08M 2025-09
Heron Therapeutics USD 229.4M 18.48M 2025-09
Insmed USD 1.93B 149.77M 2025-09
Integra LifeSciences USD 1.14B 754K 2025-09
Intrexon USD 23.72M 45.04M 2024-06
J&J USD 54.61B 113M 2025-09
Karyopharm Therapeutics USD 89.75M 8.12M 2025-09
Ligand Pharmaceuticals USD 753.92M 400.98M 2025-09
MacroGenics USD 232.09M 27.15M 2025-09
Merit Medical Systems USD 985.53M 62.46M 2025-09
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sanofi EUR 30.95B 3.09B 2025-12
Smith & Nephew USD 4.63B 169M 2025-12
Stryker USD 14.76B 1.04B 2025-12
Surmodics USD 81.3M 948K 2024-09
Veracyte USD 449.22M 34.54M 2025-09
Xencor USD 518.44M 5.29M 2025-09
Zimmer Biomet Holdings USD 5.12B 715M 2025-12


Anika Therapeutics Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.